02.06.2013 Views

Aanesthetic Agents for Day Surgery - NIHR Health Technology ...

Aanesthetic Agents for Day Surgery - NIHR Health Technology ...

Aanesthetic Agents for Day Surgery - NIHR Health Technology ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

Summary<br />

Cumulative %<br />

Positive net benefit<br />

Recruitment<br />

The overall recruitment rate was 75%, and 25<br />

patients were withdrawn, providing 322 patients in<br />

the study. Nineteen per cent of patients were lost<br />

to follow-up 7 days after discharge.<br />

Clinical outcomes<br />

• Children were significantly more sick with sevoflurane/sevoflurane<br />

than with propofol/halothane.<br />

• No gender difference was found in terms of<br />

the rate of PONV. An additional risk factor<br />

associated with PONV is agitation in recovery.<br />

• The overall overnight admission rate was<br />

only 1.2%.<br />

Resource use<br />

• The length of hospital stay was not different<br />

between randomisation arms, but variable costs<br />

and total costs were significantly higher in the<br />

sevoflurane/sevoflurane arm.<br />

• There were extremely low postdischarge costs to<br />

both the NHS and the parents, demonstrating<br />

that day-surgery discharge policies were<br />

clinically appropriate.<br />

© Queen’s Printer and Controller of HMSO 2002. All rights reserved.<br />

<strong>Health</strong> <strong>Technology</strong> Assessment 2002; Vol. 6: No. 30<br />

Positive net cost<br />

–1500 –1300 –1100 –900 –700 –500 –300 –100 0 100 300 500 700<br />

Net cost (£)<br />

FIGURE 27 The cumulative percentage of the net cost <strong>for</strong> each anaesthetic regimen in the paediatric study (–––, sevoflurane/<br />

sevoflurane; - - -, propofol/halothane)<br />

Patient preferences and CV<br />

• Parents whose children had not had the mask<br />

(sevoflurane) be<strong>for</strong>e did not want it in the<br />

future. Parents whose children had not had the<br />

injection (propofol) be<strong>for</strong>e did not want it in<br />

the future. On the whole, parents were happy<br />

with the technique their children received.<br />

• Those parents who would choose the same<br />

induction method in the future as that which<br />

their child had received tended to give higher<br />

CVs than those who chose the alternative<br />

method <strong>for</strong> induction, but the differences<br />

were not statistically significant.<br />

• Parents did not give higher CVs <strong>for</strong> avoiding<br />

PONV if their child had received sevoflurane/<br />

sevoflurane. Parents gave higher CVs <strong>for</strong> their<br />

children to avoid PONV than did the adult<br />

patients to avoid PONV themselves.<br />

• There was no significant difference in CVs<br />

<strong>for</strong> maintenance anaesthesia between those<br />

parents whose children had and had not<br />

experienced PONV.<br />

Cost-effectiveness analysis<br />

Propofol/halothane was the most effective<br />

and least costly (£3.50 per patient, rate of<br />

79

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!